GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: Example 69 [WO2022208391A1]
Compound class:
Synthetic organic
Comment: Polfurmetinib is the INN for a MEK tyrosine kinase inhibitor with antineoplastic potential, from INN proposed list 133 (10th July 2025). The structure is claimed as Example 69 in Pfizer patent WO2022208391A1 [1]. Pfizer have a brain-penetrant MEK inhibitor (PF-07799544) in clinical development, but its structure has not been disclosed (August 2025).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
8-(2-fluoro-4-methylsulfanylanilino)-2-(2-hydroxyethoxy)-7-methyl-3,4-dihydro-2,7-naphthyridine-1,6-dione |
International Nonproprietary Names ![]() |
|
INN number | INN |
13767 | polfurmetinib |
Synonyms ![]() |
Example 69 [WO2022208391A1] |
Database Links ![]() |
|
CAS Registry No. | 2845151-86-0 (source: WHO INN record) |
PubChem CID | 165386441 |
Search Google for chemical match using the InChIKey | TURWFFGYNJNSFK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | TURWFFGYNJNSFK |
Search PubMed clinical trials | polfurmetinib |
Search PubMed titles | polfurmetinib |
Search PubMed titles/abstracts | polfurmetinib |
UniChem Compound Search for chemical match using the InChIKey | TURWFFGYNJNSFK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | TURWFFGYNJNSFK-UHFFFAOYSA-N |